Sort
23,748 grants matching “melanoma”
Nanoconjugate delivery of proliferation and checkpoint inhibitors to treat glial tumors
$570,320Julia Y Ljubimova · Cedars-Sinai Medical Center · R01 · FY2020 · CA
Optimized ex vivo expansion of anti-tumor Th1 and Tc1 for adoptive immunotherapy
$570,144Mary L. Disis · University Of Washington · R01 · FY2014 · CA
PD-1/PD-L1 modulation in cancer therapy
$570,133Drew M. Pardoll · Johns Hopkins University · R01 · FY2024 · CA
Discovery of Glutaryl-CoA Dehydrogenase inhibitors for melanoma and pancreatic cancer
$569,944Eduard A. Sergienko · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2022 · CA
Multidisciplinary Collaborative Clinical Research, Core Facilities and Other Clinical Services in NIDDK Program Area Diseases
$569,792James Balow · National Institute Of Diabetes And Digestive And Kidney Diseases · ZID · FY2016 · DK
Dissecting the tumor-intrinsic and -extrinsic roles of TBK1 in tumor immunity
$569,782Russell William Jenkins · Medical University Of South Carolina · R37 · FY2025 · CA
Regulation of Ras-Dependent Signal Transduction Pathways
$569,682Deborah Morrison · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Identification and assessment of unconventional tumor-associated antigens as potential targets for cytotoxic T-cell based immunotherapy of cancer
$569,619Gregory A Lizee · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
The role of Staphylococcus aureus aggregate formation in establishing biofilms in chronic orthopaedic periprosthetic joint infection.
$569,522Paul Stoodley · Ohio State University · R01 · FY2018 · GM
ITIM-receptors for cancer treatment
$569,405Chengcheng Zhang · Ut Southwestern Medical Center · R01 · FY2023 · CA
Understanding how metabolic heterogeneity in cancer affects the tumor microenvironment and anti-tumor immunity
$569,307Susan M Kaech · Salk Institute For Biological Studies · R01 · FY2024 · CA
The Role of T Cell Avidity in Determining Tumor Immunity and Autoimmunity
$569,184Arthur Hurwitz · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
The Role of T Cell Avidity in Determining Tumor Immunity and Autoimmunity
$569,136Arthur Hurwitz · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Characterization of human antibodies to sialyl-Lewis A (sLeA) derived from patien
$569,051Wolfgang W Scholz · Mabvax Therapeutics, Inc. · R42 · FY2011 · CA
Advancing Precision Oncology in a Humanized, Fully Autologous Mouse Model
$569,047Ryan C Fields · Washington University · R01 · FY2024 · CA
Targeting lentiviruses to infect chosen cells
$568,888Pin Wang · University Of Southern California · R01 · FY2007 · AI
Applying Genomic Dosimeters of UV Damage to Predicting Skin Cancer Risk
$568,838Douglas E Brash · Yale University · R01 · FY2021 · ES
Induction of autosis to overcome resistance in adoptive cell therapy for solid tumors
$568,682Yong Lu · Methodist Hospital Research Institute · R01 · FY2025 · CA
Overcoming the immune-suppressive tumor microenvironment through in situ vaccination nanotechnology.
$568,456Nicole Franziska Steinmetz · University Of California, San Diego · U01 · FY2019 · CA
Fiber bundle-based divided-pupil confocal endoscope
$568,422Milind Rajadhyaksha · Sloan-Kettering Inst Can Research · R01 · FY2011 · CA
Systematic interrogation of the pancreatic cancer microenvironment in patient-derived specimens
$568,413William C Hahn · Dana-Farber Cancer Inst · U01 · FY2021 · CA
ENHANCED DEVELOPMENT OF THE XIPHOPHORUS MODEL SYSTEM
$568,113Ronald Walter · Texas State University · R24 · FY2015 · OD
(8) Mechanisms of autoimmune endocrine diseases in patients receiving checkpoint inhibitors
$568,064Kevan C Herold · Yale University · R01 · FY2019 · CA
Cancer Deep Phenotype Extraction from Electronic Medical Records
$567,937Guergana K. Savova · Boston Children'S Hospital · U24 · FY2017 · CA
G alpha-q/11 Signaling and Inhibition in Ocular Melanoma
$567,921Kendall Jay Blumer · Washington University · R01 · FY2022 · CA